MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST002274/mwtabprimaryOK200MetabolomicsMass SpectrometryESIHomo Sapienshttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST002274Genotype:C133W | Treatment:4hGenotype:Wild-type | Treatment:4hGenotype:C133W | Treatment:1hGenotype:C133W | Treatment:15minGenotype:Wild-type | Treatment:15minGenotype:Wild-type | Treatment:1hCultured CellsSalk Institute for Biological StudiesReversed phase POSITIVE ION MODE.MetabolomicsWorkbenchDHCer d18:0/16:0DHCer d18:0/24:1DHCer d18:0/24:0Cer d18:1/16:0Cer d18:1/24:1Cer d18:1/24:0Plasma Membranes, Malignant Neoplasm, plasma membrane invagination, synthesize, integral component of plasma membrane, Neoplasms, postnatal development, Cytoplasmic Membrane, Benign Neoplasm, growth and development, Endocytoses, nonselective vesicle endocytosis, Tumor, Malignant, Cell, development, cellular membrane, MT, Benign, Neoplasm, Cell., bacterial inner membrane, Cell Membranes, multicellular organismal biosynthetic process, Plasma, Membranes, single-organism biosynthetic process, primary cancer, cell membrane, growth pattern, Malignancy, non-developmental growth, postnatal growth, Benign Neoplasms, Cancers, Membrane, malignant tumor, inner endospore membrane, Malignant Neoplasms, Cytoplasmic, Neoplasias, plasma membrane lipid bilayer, malignant neoplasm, Cytoplasmic Membranes, plasmalemma, Plasma Membrane, Malignancies, cytoplasmic membrane, growth, integral to plasma membrane, Neoplasia, Cancer, Tumorsbackward, reversed.false1-deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cellsST0022749606